Plasma total homocysteine levels in subjects with hyperinsulinemia. 2000

H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
Diabetes Unit and Geriatric Unit, Department of Medicine, School of Public Health and Community Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. baron@hadassah.org.il

OBJECTIVE Hyperhomocysteinemia as well as insulin resistance are considered to be risk factors for the development of coronary artery disease. This study was aimed at determining whether any relationship between plasma insulin and glucose levels and total plasma homocysteine (tHcy) concentrations exists in a population based survey performed 10 years apart. METHODS A cross-sectional study was undertaken during the years 1986-87 to examine risk factors for diabetes and for coronary artery disease (CAD) in the Jewish population of Jerusalem. Ten years later two groups of individuals were invited for re-examination. METHODS Two groups of individuals were examined: the first one consisted of nondiabetic subjects (n = 86), who had hyperinsulinemia 10 years previously (at the first visit), the second group consisted of normoinsulinemic nondiabetic individuals (n = 265) who had initially normal glucose and insulin levels. METHODS Metabolic, biochemical and anthropomorphic features were determined. Fasting and post load glucose, as well as insulin concentrations on fasting and 2 h post glucose load were measured at the first and second visits. Plasma tHcy and folic acid were determined only at the second visit. RESULTS The results demonstrated a significant negative correlation between plasma tHcy levels and insulin levels at the second visit. No difference was found in folic acid levels between these two groups. CONCLUSIONS In general, hyperinsulinemia and hyperhomocysteinemia are both related to an increased incidence of CAD. In our population most of the subjects examined had tHcy levels within the normal range and only a few demonstrated very high levels. However, negative association between insulin levels and tHcy concentrations was found. Possible explanations for this finding are discussed.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008019 Life Style Typical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed) Lifestyle Factors,Life Style Induced Illness,Lifestyle,Factor, Lifestyle,Life Styles,Lifestyle Factor,Lifestyles
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005492 Folic Acid A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. Pteroylglutamic Acid,Vitamin M,Folacin,Folate,Folic Acid, (D)-Isomer,Folic Acid, (DL)-Isomer,Folic Acid, Calcium Salt (1:1),Folic Acid, Monopotassium Salt,Folic Acid, Monosodium Salt,Folic Acid, Potassium Salt,Folic Acid, Sodium Salt,Folvite,Vitamin B9,B9, Vitamin

Related Publications

H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
February 2002, The Journal of nutritional biochemistry,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
December 2000, Diabetes care,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
July 1998, Atherosclerosis,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
January 2014, BioMed research international,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
January 1991, Clinical chemistry,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
October 1996, The American journal of clinical nutrition,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
January 1998, Metabolism: clinical and experimental,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
March 2002, Canadian journal of physiology and pharmacology,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
February 2007, European heart journal,
H Bar-On, and M Kidron, and Y Friedlander, and A Ben-Yehuda, and J Selhub, and I H Rosenberg, and G Friedman
June 1998, Metabolism: clinical and experimental,
Copied contents to your clipboard!